This is a preview of subscription content, log in via an institution to check access.
Change history
09 August 2017
In the July 2017 issue, Janssen's fynomer drug for psoriasis was said to be discontinued “when it induced rheumatoid arthritis.” In fact, it was discontinued “after it induced transient rashes and muscle pain.” The error was corrected in the html and pdf versions of the article on 9 August 2017.
13 April 2018
In the version of this article initially published, it was stated that affibodies were invented by "a group led by Fredrik Frejd," instead of "researchers at the Royal Institute of Technology, Stockholm, and Fredrik Frejd." The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Owens, B. Faster, deeper, smaller—the rise of antibody-like scaffolds. Nat Biotechnol 35, 602–603 (2017). https://doi.org/10.1038/nbt0717-602
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0717-602
- Springer Nature America, Inc.
This article is cited by
-
Design of an artificial phage-display library based on a new scaffold improved for average stability of the randomized proteins
Scientific Reports (2023)
-
Recombinant antibodies and their use for food immunoanalysis
Analytical and Bioanalytical Chemistry (2022)
-
Current trends in biopharmaceuticals production in Escherichia coli
Biotechnology Letters (2022)
-
A ligand-based system for receptor-specific delivery of proteins
Scientific Reports (2019)
-
A protein scaffold, engineered SPINK2, for generation of inhibitors with high affinity and specificity against target proteases
Scientific Reports (2019)